Lactic acidosis and liver mitochondrial alterations during a treatment with zidovudine;Acidose lactique et alterations mitochondriales hepatiques au cours d'un traitement par zidovudine

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 12, 1997, Pages 979-981

  Charton Bain, Marie Clotilde ^a,b   Flamant, Martin ^a   Aubertin, Jean Marc ^a   Belair, Marie France ^a   Gilquin, Jacques ^a   Kazatchkine, Michel ^a   Bruneval, Patrick ^a  

^a HÔPITAL BROUSSAIS   (France)

^b INSTITUT PAOLI CALMETTES   (France)

Author keywords

HIV; Lactic acidosis; Liver; Liver failure; Liver toxicity; Mitochondria; Zidovudine

Indexed keywords

ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG MECHANISM; HUMAN; LACTIC ACIDOSIS; LIVER MITOCHONDRION; LIVER TOXICITY; MALE; MITOCHONDRIAL MYOPATHY; MYOPATHY; PATHOPHYSIOLOGY; STEATOSIS; ULTRASTRUCTURE; CHEMICALLY INDUCED DISORDER; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

ACIDOSIS, LACTIC; ADULT; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; MALE; MITOCHONDRIA, LIVER; REVERSE TRANSCRIPTASE INHIBITORS; ZIDOVUDINE;

EID: 0031325014     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lewis W, Dalakas MC. Mitochondrial toxicity of antiviral drugs. Nat Med 1995;1:417-22.
2. Chattha G, Arieff AI, Cummings C, Tierney LM. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med 1993;118:37-9.
3. Gopinath R, Hutcheon M, Cheema-Dhaddli S, Halperin M. Chronic lactic acidosis in a patient with acquired immunodeficiency syndrome and mitochondrial myopathy: biochemical studies. J Am Soc Nephrol 1992;3:1212-9.
4. Pezeshkpour G, Illa I, Dalakas MC. Ultrastructural characteristics and DNA immunocytochemistry in human immunodeficiency virus and zidovudine-associated myopathies. Hum Pathol 1991;22: 1281-8.
5. Chen SCA, Barker SM, Mitchell DH, Stevens SMB. O'Neill P, Cunningham AL. Concurrent zidovudine-induced myopathy and hepatotoxicity in patients treated for human immunodeficiency virus (HIV) infection. Pathology 1992;24:109-11.
6. Chariot P, Dubreuil-Lemaire AL, Gherardi R. Lactic acidosis and AIDS (comment). Ann Intern Med 1993;119: 344-5.
7. Le Bras P, D'Oiron R, Quertainmont Y, Halfon P, Caquet R. Metabolic, hepatic and muscular changes during zidovudine therapy: a drug-induced mitochondrial disease ? AIDS 1994;8: 716-7.
8. Olano JP, Borucki MJ, Wen JW, Haque AK. Massive hepatic steatosis and lactic acidosis in a patient with AIDS who was receiving zidovudine. Clin Infect Dis 1995;21:973-6.
9. McKenzie R, Fried MW, Sallie R. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B. N Engl J Med 1995;33:1099-105.
10. Freiman JP, Helfert KE, Hamrell MR, Stein DS. Hepatomegaly with severe steatosis in HIV-seropositive patients. AIDS 1993;7: 379-85.
11. Jolliet P, Widmann JJ. Reye's syndrome in adult with AIDS. Lancet 1990;335:1457.
12. Causse X, Gargot D, Michenet P. Stéatoses hépatiques. Première partie: Stéatoses macrovésiculaires. Gastroenterol Clin Biol 1995;19:58-65.
13. Frénaux E, Pessayre D. Stéatoses, phospholipidoses, et lésions pseudo-alcooliques hépatiques d'origine médicamenteuse. Gastroenterol Clin Biol 1993;17:H36-43.
14. Causse X, Gargot D, Michenet P. Stéatoses hépatiques. Deuxième partie: Stéatoses microvésiculaires. Gastroenterol Clin Biol 1995;19:66-75.
15. Corcuera T, Alonso MJ, Picazo A, Gomez F, Roldan M, Ahad M, et al. Hepatic morphological alterations induced by zidovudine (ZDV) in an experimental model. Pathol Res Pract 1996;192:182-7.